HC Surgical Specialists Limited (SGX:1B1)

Singapore · Delayed Price · Currency is SGD

0.3400

0.00 (0.00%)

At close: Oct 28, 2026

Market Cap	52.15M -2.9%
Revenue (ttm)	19.78M -4.7%
Net Income	6.98M -17.2%
EPS	0.05 -17.1%
Shares Out	153.38M
PE Ratio	7.47
Forward PE	n/a
Dividend	0.02 (6.12%)
Ex-Dividend Date	Oct 21, 2026

Volume	200
Open	0.3600
Previous Close	n/a
Day's Range	0.3400 - 0.3600
52-Week Range	0.3300 - 0.4000
Beta	-0.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Jan 11, 2027

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g... [Read more]

Industry Offices and Clinics of Doctors of Medicine

Founded 2015

Country Singapore

Stock Exchange Singapore Exchange - Catalist

Ticker Symbol 1B1

Full Company Profile

Financial Performance

In fiscal year 2026, HC Surgical Specialists's revenue was 19.78 million, a decrease of -4.72% compared to the previous year's 20.76 million. Earnings were 6.98 million, a decrease of -17.24%.

Financial Statements